Opaleye Management Inc. - IMPRIMIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of IMPRIMIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$9,550,000
-47.5%
2,500,000
+6.8%
2.53%
-29.1%
Q4 2019$18,205,000
+36.7%
2,340,000
-1.3%
3.57%
-25.8%
Q3 2019$13,319,000
-30.7%
2,370,000
+7.2%
4.82%
-17.8%
Q2 2019$19,227,000
+114.5%
2,210,000
+22.8%
5.86%
+136.1%
Q1 2019$8,964,000
-8.5%
1,800,000
+4.5%
2.48%
-32.1%
Q4 2018$9,798,000
+117.6%
1,722,000
+6.3%
3.66%
+219.0%
Q3 2018$4,503,000
+57.2%
1,620,000
+81.0%
1.15%
-4.2%
Q2 2017$2,864,000
-20.2%
895,000
+4.0%
1.20%
-33.0%
Q1 2017$3,588,000
+99.3%
860,500
+19.5%
1.79%
+68.3%
Q4 2016$1,800,000
-61.1%
720,000
-40.8%
1.06%
-56.2%
Q3 2016$4,631,000
-2.8%
1,215,381
-4.1%
2.42%
-23.9%
Q2 2016$4,766,000
-4.0%
1,267,500
+1.4%
3.18%
+2.9%
Q1 2016$4,963,000
-40.6%
1,250,000
+3.7%
3.10%
-11.4%
Q4 2015$8,351,000
+7.9%
1,205,0000.0%3.49%
-8.3%
Q3 2015$7,736,000
-21.0%
1,205,0000.0%3.81%
-2.3%
Q2 2015$9,797,000
+78.5%
1,205,000
+75.4%
3.90%
+52.9%
Q1 2015$5,490,000
+30.7%
687,100
+22.7%
2.55%
+20.1%
Q4 2014$4,200,000
-99.9%
560,000
+11.4%
2.12%
-27.0%
Q3 2014$3,728,550,000502,5002.91%
Other shareholders
IMPRIMIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,205,000$8,351,0003.49%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 622,744$4,316,0001.61%
MARATHON CAPITAL MANAGEMENT 25,000$173,0000.09%
Granite Investment Partners, LLC 125,251$868,0000.08%
REGIONS FINANCIAL CORP 30,500$211,0000.00%
CIBC Private Wealth Group, LLC 29,297$203,0000.00%
Tower Research Capital LLC (TRC) 576$4,0000.00%
Formidable Asset Management, LLC 300$2,0000.00%
BlackRock Investment Management, LLC 1,211$8,0000.00%
CITIGROUP INC 25$00.00%
View complete list of IMPRIMIS PHARMACEUTICALS INC shareholders